Zobrazeno 1 - 10
of 15
pro vyhledávání: '"'Eva Maria Pastor Arroyo"'
Autor:
Cornelia Bieri, Arezoo Daryadel, Carla Bettoni, Eva-Maria Pastor-Arroyo, Udo Schnitzbauer, Nati Hernando, Carsten A. Wagner
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Kidneys are key regulators of phosphate homeostasis. Biallelic mutations of the renal Na+/phosphate cotransporter SLC34A1/NaPi-IIa cause idiopathic infantile hypercalcemia, whereas monoallelic mutations were frequently noted in adults with k
Externí odkaz:
https://doaj.org/article/c93fb8d4d8034a898d5aac56981a28cf
Autor:
Eva Maria Pastor-Arroyo, Josep M. Monné Rodriguez, Giovanni Pellegrini, Carla Bettoni, Moshe Levi, Nati Hernando, Carsten A. Wagner
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Absorption of dietary phosphate (Pi) across intestinal epithelia is a regulated process mediated by transcellular and paracellular pathways. Although hyperphosphatemia is a risk factor for the development of cardiovascular disease, the amoun
Externí odkaz:
https://doaj.org/article/6cd0a69ddd7f4f809f809bc3e2f64873
Autor:
Daniela Egli-Spichtig, Martin Y. H. Zhang, Alfred Li, Eva Maria Pastor Arroyo, Nati Hernando, Carsten A. Wagner, Wenhan Chang, Farzana Perwad
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Fibroblast growth factor 23 (FGF23) is a bone-derived endocrine hormone that regulates phosphate and vitamin D metabolism. In models of FGF23 excess, renal deoxyribonuclease 1 (Dnase1) mRNA expression is downregulated. Dnase-1 is an endonucl
Externí odkaz:
https://doaj.org/article/89d7811941be4841a8aed0d4f045fe9c
Autor:
Elena Layunta, Eva Maria Pastor Arroyo, Larissa Kägi, Linto Thomas, Moshe Levi, Nati Hernando, Carsten A. Wagner
Publikováno v:
Cellular Physiology and Biochemistry, Vol 52, Iss 4, Pp 838-849 (2019)
Externí odkaz:
https://doaj.org/article/cbb4f02e54f542178756cefd745a3983
Autor:
Daniela Egli-Spichtig, Ahmad Kamal Hamid, Eva Maria Pastor Arroyo, Markus Ketteler, Andrzej Wiecek, Alexander R Rosenkranz, Andreas Pasch, Horst Lorenz, Burkhard Hellmann, Michael Karus, Richard Ammer, Isabel Rubio-Aliaga, Carsten A Wagner
Publikováno v:
Clinical Kidney Journal.
Background Hyperphosphatemia is associated with increased mortality and cardiovascular morbidity of end-stage kidney failure (ESKF) patients. Managing serum phosphate in ESKF patients is challenging and mostly based on limiting intestinal phosphate a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85caa02b4a3d8a2b4f9215aee3dc6ba8
https://doi.org/10.1093/ckj/sfad040
https://doi.org/10.1093/ckj/sfad040
Autor:
Chahira Katamesh-Benabbas, Timothy R. Arnett, Olivier Bonny, Eva Maria Pastor Arroyo, Klaus Seuwen, Jürg A. Gasser, Carla Bettoni, Carsten A. Wagner, Pedro Henrique Imenez Silva, Thomas Knöpfel, Kessara Chan, Marie-Gabrielle Ludwig, A Brandao-Burch
Publikováno v:
Kidney International. 97:920-933
Hypercalciuria is a common feature during metabolic acidosis and associates to nephrolithiasis and nephrocalcinosis. The mechanisms sensing acidosis and inducing increased urinary calcium excretion are still unknown. Here we tested whether mice defic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25c58aa5f8877b4b7cbfe88f6e744275
https://doi.org/10.1016/j.kint.2019.12.006
https://doi.org/10.1016/j.kint.2019.12.006
Autor:
Eva Maria Pastor Arroyo, Nima Yassini, Elif Sakiri, Giancarlo Russo, Soline Bourgeois, Nilufar Mohebbi, Kerstin Amann, Nicole Joller, Carsten A. Wagner, Pedro Henrique Imenez Silva
Chronic kidney disease (CKD) affects approximately 10–13% of the population worldwide and halting its progression is a major clinical challenge. Metabolic acidosis is both a consequence and a possible driver of CKD progression. Alkali therapy count
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::368bb7d7ad64b231096c4e2c9a9fc950
Autor:
Carsten A. Wagner, Nati Hernando, Larissa Kägi, Eva Maria Pastor Arroyo, Moshe Levi, Elena Layunta, Linto Thomas
Publikováno v:
Cellular Physiology and Biochemistry, Vol 52, Iss 4, Pp 838-849 (2019)
BACKGROUND/AIMS Phosphate (Pi) homeostasis is controlled by the intestine and kidneys whose capacities to transport Pi are under endocrine control. Several studies point to intestinal absorption as a therapeutic target to modulate Pi homeostasis. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d00db5081c289764bbd97d8f05c198d0
https://doi.org/10.33594/000000058
https://doi.org/10.33594/000000058
Autor:
Arezoo Daryadel, Isabel Rubio-Aliaga, Soline Bourgeois, Marko Ugrica, Nicole Gehring, Eva-Maria Pastor-Arroyo, Nati Hernando, Carla Bettoni, Carsten A. Wagner
Background Phosphate intake has increased in the last decades due to a higher consumption of processed foods. This higher intake is detrimental for patients with chronic kidney disease, increasing mortality and cardiovascular disease risk and acceler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae11f63bc4e6c2f2a99a5f11d2e2b8ce
https://www.zora.uzh.ch/id/eprint/200534/
https://www.zora.uzh.ch/id/eprint/200534/
Autor:
Cornelia Bieri, Arezoo Daryadel, Carla Bettoni, Eva-Maria Pastor-Arroyo, Udo Schnitzbauer, Nati Hernando, Carsten A. Wagner
Publikováno v:
Scientific reports. 12(1)
Kidneys are key regulators of phosphate homeostasis. Biallelic mutations of the renal Na+/phosphate cotransporter SLC34A1/NaPi-IIa cause idiopathic infantile hypercalcemia, whereas monoallelic mutations were frequently noted in adults with kidney sto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38ae92a0d94fb1f396b0d8f3760405ee
https://pubmed.ncbi.nlm.nih.gov/35414099
https://pubmed.ncbi.nlm.nih.gov/35414099